[1] |
Stender S, Frikke-Schmidt R, Nordestgaard BG, et al. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease[J]. J Am Coll Cardiol, 2014, 63(20):2121-2128.
|
[2] |
von Kampen O, Buch S, Nothnagel M, et al. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus[J]. Hepatology, 2013, 57(6):2407-2417.
|
[3] |
Hancock-Cerutti W, Rader DJ. Opposing effects of ABCG5/8 function on myocardial infarction and gallstone disease[J]. J Am Coll Cardiol, 2014, 63(20):2129-2130.
|
[4] |
Cariati A, Piromalli E. Could omega-3 fatty acid prolonged intake reduce the incidence of symptomatic cholesterol gallstones disease?[J]. Clin Nutr, 2013, 32(3):486-487.
|
[5] |
Marschall HU, Krawczyk M, Grunhage F, et al. Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1[J]. Liver Int, 2013, 33(6):904-908.
|
[6] |
Simonsen MH, Erichsen R, Froslev T, et al. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study[J]. Drug Saf, 2013, 36(12):1189-1197.
|
[7] |
Di Ciaula A, Wang DQ, Garruti G, et al. Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review[J]. Curr Med Chem, 2014, 21(12):1435-1447.
|
[8] |
Wang C, Guo Y, Wang J, et al. Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression[J]. Mol Med Rep, 2015, 11(3):2147-2152.
|
[9] |
Ma KY, Yang N, Jiao R, et al. Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5/8 in hamsters[J]. Mol Nutr Food Res, 2011, 55(2):247-258.
|
[10] |
Kerr ID, Haider AJ, Gelissen IC. The ABCG family of membrane-associated transporters: you don't have to be big to be mighty[J]. Br J Pharmacol, 2011, 164(7):1767-1779.
|
[11] |
Gao X, Gu H, Li G, et al. Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux[J]. Biochim Biophys Acta, 2012, 1821(3):552-559.
|
[12] |
Pandey S. Genetic basis of gall stone disease[J]. Hepatology, 2013, 58(4):1519.
|
[13] |
Liang Y, Chen J, Zuo Y, et al. Blueberry anthocyanins at doses of 0.5 and 1 % lowered plasma cholesterol by increasing fecal excretion of acidic and neutral sterols in hamsters fed a cholesterol-enriched diet[J]. Eur J Nutr, 2013, 52(3):869-875.
|
[14] |
Ghanbari-Niaki A, Rahmati-Ahmadabad S, Zare-Kookandeh N. ABCG8 gene responses to 8 weeks treadmill running with or without Pistachia Atlantica (Baneh) extraction in female rats[J]. Int J Endocrinol Metab, 2012, 10(4):604-610.
|
[15] |
Wang F, Li G, Gu HM, et al. Characterization of the role of a highly conserved sequence in ATP binding cassette transporter G (ABCG) family in ABCG1 stability, oligomerization, and trafficking[J]. Biochemistry, 2013, 52(52):9497-9509.
|
[16] |
Ghanbari-Niaki A, Zare-Kookandeh N, Zare-Kookandeh A. ABCG5 gene responses to treadmill running with or without administration of Pistachio atlantica in female rats[J]. Iran J Basic Med Sci, 2014, 17(3):162-171.
|
[17] |
Hirschfield GM, Chapman RW, Karlsen TH, et al. The genetics of complex cholestatic disorders[J]. Gastroenterology, 2013, 144(7):1357-1374.
|
[18] |
Jakulj L, Vissers MN, Tanck MW, et al. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis[J]. J Lipid Res, 2010, 51(10):3016-3023.
|